Short Interest in Cosmos Health Inc. (NASDAQ:COSM) Increases By 148.9%

Cosmos Health Inc. (NASDAQ:COSMGet Free Report) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totalling 761,500 shares, an increase of 148.9% from the June 15th total of 305,900 shares. Based on an average daily volume of 1,900,000 shares, the short-interest ratio is currently 0.4 days. Approximately 5.0% of the shares of the stock are sold short.

Cosmos Health Stock Performance

NASDAQ COSM opened at $1.29 on Friday. The business has a fifty day moving average price of $0.78 and a two-hundred day moving average price of $0.83. Cosmos Health has a fifty-two week low of $0.47 and a fifty-two week high of $3.42.

Hedge Funds Weigh In On Cosmos Health

A hedge fund recently bought a new stake in Cosmos Health stock. Armistice Capital LLC bought a new stake in Cosmos Health Inc. (NASDAQ:COSMFree Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,334,937 shares of the company’s stock, valued at approximately $1,882,000. Armistice Capital LLC owned about 7.89% of Cosmos Health as of its most recent SEC filing. 12.61% of the stock is currently owned by institutional investors and hedge funds.

Cosmos Health Company Profile

(Get Free Report)

Cosmos Health Inc provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies.

See Also

Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.